Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

UT Southwestern Medical Center

UT Southwestern Medical Center in Dallas, Texas, United States is listed as a site for 772 registered clinical trials, 276 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 772
Ongoing 276

This page covers the site record UT Southwestern Medical Center in Dallas, Texas, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the UT Southwestern Medical Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 772 trials counted.

  • Phase 1 58 trials
  • Phase 1/2 53 trials
  • Phase 2 160 trials
  • Phase 2/3 16 trials
  • Phase 3 156 trials
  • Phase 4 50 trials
  • Not applicable 137 trials
  • Observational 131 trials
  • Expanded access 10 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 278 trials
  • Completed 352 trials
  • Terminated 122 trials
  • Other 20 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Expanded access, Unknown)

Top of scale: 72

1995: 1 trials (Phase 3 1) 1996: 1 trials (Observational 1) 1998: 1 trials (Observational 1) 2000: 5 trials (Observational 1, Phase 4 1, Phase 3 3) 2002: 1 trials (Phase 3 1) 2003: 3 trials (Phase 3 1, Phase 2 2) 2004: 7 trials (Observational 2, Phase 4 1, Phase 3 3, Phase 2 1) 2005: 7 trials (Not applicable 2, Phase 3 5) 2006: 9 trials (Other 1, Observational 1, Not applicable 2, Phase 4 1, Phase 3 1, Phase 2/3 1, Phase 2 2) 2007: 14 trials (Observational 5, Not applicable 3, Phase 4 1, Phase 3 2, Phase 2 3) 2008: 13 trials (Observational 2, Not applicable 6, Phase 4 1, Phase 3 2, Phase 2 2) 2009: 21 trials (Observational 2, Not applicable 3, Phase 4 4, Phase 3 2, Phase 2 7, Phase 1/2 2, Phase 1 1) 2010: 14 trials (Observational 3, Not applicable 2, Phase 4 2, Phase 3 2, Phase 2 3, Phase 1 2) 2011: 18 trials (Observational 1, Not applicable 2, Phase 4 1, Phase 3 2, Phase 2 8, Phase 1/2 3, Phase 1 1) 2012: 26 trials (Observational 5, Not applicable 5, Phase 4 1, Phase 3 5, Phase 2/3 1, Phase 2 5, Phase 1/2 2, Phase 1 2) 2013: 35 trials (Observational 6, Not applicable 2, Phase 4 2, Phase 3 9, Phase 2/3 2, Phase 2 9, Phase 1/2 4, Phase 1 1) 2014: 37 trials (Observational 9, Not applicable 3, Phase 4 5, Phase 3 4, Phase 2 7, Phase 1 9) 2015: 36 trials (Other 1, Observational 4, Not applicable 7, Phase 4 1, Phase 3 8, Phase 2 9, Phase 1/2 3, Phase 1 3) 2016: 36 trials (Observational 5, Not applicable 8, Phase 4 5, Phase 3 4, Phase 2/3 1, Phase 2 8, Phase 1/2 1, Phase 1 4) 2017: 42 trials (Observational 4, Not applicable 9, Phase 4 2, Phase 3 3, Phase 2/3 3, Phase 2 14, Phase 1/2 3, Phase 1 4) 2018: 43 trials (Observational 7, Not applicable 7, Phase 4 3, Phase 3 9, Phase 2/3 1, Phase 2 8, Phase 1/2 5, Phase 1 3) 2019: 51 trials (Observational 8, Not applicable 9, Phase 4 1, Phase 3 15, Phase 2 9, Phase 1/2 4, Phase 1 5) 2020: 34 trials (Observational 5, Not applicable 3, Phase 4 2, Phase 3 9, Phase 2 9, Phase 1/2 4, Phase 1 2) 2021: 50 trials (Observational 10, Not applicable 9, Phase 4 5, Phase 3 8, Phase 2 8, Phase 1/2 6, Phase 1 4) 2022: 58 trials (Observational 14, Not applicable 13, Phase 4 2, Phase 3 11, Phase 2/3 3, Phase 2 8, Phase 1/2 2, Phase 1 5) 2023: 50 trials (Observational 6, Not applicable 9, Phase 4 4, Phase 3 11, Phase 2/3 1, Phase 2 13, Phase 1/2 4, Phase 1 2) 2024: 72 trials (Observational 15, Not applicable 17, Phase 4 2, Phase 3 13, Phase 2/3 2, Phase 2 15, Phase 1/2 4, Phase 1 4) 2025: 41 trials (Observational 6, Not applicable 9, Phase 4 1, Phase 3 15, Phase 2/3 1, Phase 2 3, Phase 1/2 2, Phase 1 4)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 36
2025 41
2024 72
2023 50
2022 58
2021 50
2020 34
2019 51
2018 43
2017 42

Showing 10 of 29 years.

Start your 14-day trial Email me all 29 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 772 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 245 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 432 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF